Product Images Gabapentin

This appears to be a table or chart showing the mean pain score for different treatments over a period of 43 weeks. The treatments include a placebo, and two different dosages of Gabapentin (1800 mg/day and 2400 mg/day). The chart also includes a baseline measurement and indicates that there are two dosing periods (4 weeks and an unspecified number of weeks). There is not enough context to determine exactly what type of pain or condition is being studied.*

The text is describing the proportion of responders (patients with a 2 50% reduction in pain score), and their endpoint, in controlled PHN studies. The studies are represented in Figure 3, with p-values shown for significance. Study 1 had 3% responders on placebo, 12% on GBP 3600, and 14% on GBP 2400, while Study 2 had 2% responders on placebo, 2% responders on GBP 1800, and 10% responders on GBP 2400.*

This text provides two mathematical formulas commonly used in medical settings. The first formula calculates an estimated maximum heart rate based on age and weight. The second formula calculates the creatinine clearance rate, an indicator of kidney function, using serum creatinine levels. In the case of female patients, the result of the creatinine clearance rate calculation is multiplied by 0.85.*

This is a description of a Gabapentin medication with product details including dosage, quantity, and manufacturer information. The medication comes in a box with 30 tablets, and each tablet has 800mg of Gabapentin. The NDC number is 50436-7210-1. The manufacturer of the medication is Glermarl Pharm Ltd located in Goa, India. The drug has an expiration date, and it should be kept in controlled temperature at 25°C or 77°F. The medication is prescription only and the lot number is identified as XXXXKX.*

This text is not-available for generating a useful description. It seems to be a single letter and a word that could potentially be a company name.*

The text is not-available.*